Longer Follow up of T-Prolymphocytic Leukaemia Patients Treated with Alemtuzumab (Campath-1H) Shows Improved Survival and Higher Response Rates in Previously Untreated Patients.

AuthID
 P-000-MCT
11
Author(s)
Matutes, E
·
Cazin, B
·
Tjonnfiord, GE
·
Parreira, A
·
Leoni, P
·
Rassam, SMB
·
Roques, T
·
Ketterer, N
·
Lakhani, A
·
Catovsky, D
Document Type
Abstract
Year published
2002
Published
in BLOOD, ISSN: 0006-4971
Volume: 100, Issue: 11, Pages: 364A-364A (1)
Conference
44Th Annual Meeting of the American-Society-Of-Hematology, Date: DEC 06-10, 2002, Location: PHILADELPHIA, PENNSYLVANIA, Sponsors: Amer Soc Hematol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000179184701410
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service